Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cipla
Cantor Fitzgerald
UBS
Baxter
Fuji
Citi
Fish and Richardson
QuintilesIMS
Federal Trade Commission

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,399,777

« Back to Dashboard

Which drugs does patent 6,399,777 protect, and when does it expire?

Patent 6,399,777 protects GEODON and is included in one NDA.

This patent has fifty-four patent family members in forty-four countries.
Summary for Patent: 6,399,777
Title: Inclusion complexes of aryl-heterocyclic salts
Abstract:The esylate, mesylate, and tartrate salts of ziprasidone exhibit excellent solubilities in cyclodextrins.
Inventor(s): Kim; Yesook (Branford, CT), Johnson; Kevin C. (Niantic, CT), Shanker; Ravi M. (Groton, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/850,658
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 6,399,777

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,399,777

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,232,304 Inclusion complexes of aryl-heterocyclic salts ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,399,777

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey 9802231 ➤ Subscribe
Tunisia SN97075 ➤ Subscribe
Slovakia 282032 ➤ Subscribe
Slovakia 150498 ➤ Subscribe
Slovenia 0900088 ➤ Subscribe
Serbia 49532 ➤ Subscribe
Yugoslavia 17297 ➤ Subscribe
Portugal 900088 ➤ Subscribe
Poland 189324 ➤ Subscribe
Poland 329928 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
Medtronic
Cipla
Daiichi Sankyo
Baxter
Express Scripts
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot